anvajo GmbH acquires 9.5 Million Euros
anvajo successfully raised 9.5 million euros in September. A strategic new investor brought in 7.5 million euros, while existing investors continued their support with 2.0 million euros. This confirms the confidence in anvajo's innovative strength and future-oriented business model. The money raised will enable anvajo to further develop its technology and drive growth.
anvajo's mission is to provide access to laboratory diagnostics for anyone, anytime, anywhere in the world. The company develops and markets point-of-care devices that analyze liquids quickly, cost-effectively and reliably. At the heart of this technology are digital holographic microscopy and a compact spectrometer, which together form the basis for the so-called fluidlabs. One of the products, the first-generation fluidlab, is already being used in various areas of medical diagnostics as well as in research and industry. It offers a cost-effective and portable solution for carrying out precise analyses - and is attracting growing interest in the target sectors. At the beginning of 2024, the second generation of the fluidlab platform was also launched on the market with a partner company.
“Our vision is better healthcare in which diseases can be detected more quickly, therapies can be developed more efficiently and their progress can be tracked more accurately”, explains Stefan Fraedrich, Founder and Managing Director of anvajo. “With the new financing, we will be able to intensify the further development of our products and open up new markets for our fluidlab platform.”
